Manual Therapy and Photobiomodulation in the Treatment of Cervical Pai

Not Applicable

Recruiting

• Conditions: Myofascial pain syndrome; trigger points; cervical pain; A01.947; C23.888.592.612.553; C05.651.550

• Registration Number: RBR-4hzsyv
• Lead Sponsor: niversidade Federal de Santa Catarina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-20
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Be between 18 and 40 years old;
Presence of active trigger point in upper trapezius;
Present pain in the cervical region beginning in up to three months;
Present pain level greater than 3 on the Visual Analog Scale in the last 30 days for the cervical region.

Exclusion Criteria

Have a BMI greater than 30;
Have whiplash injury and / or cervical pathologies such as herniated disc and thoracic outlet syndrome;
Be undergoing treatment for pain in the neck and shoulders;
Make use of analgesic, anti-inflammatory and / or muscle relaxant medications and anticoagulant medications.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain reduction, which will be assessed using the Visual Analogue Scale (VAS). EVA will be collected before the intervention, 10 minutes and 30 minutes after the intervention and at the follow-up of 1 week and 1 month.

Secondary Outcome Measures

Name	Time	Method
Decreased pressure pain threshold, which will be assessed by a pressure algometer. This value will be collected before the intervention and 30 minutes after the intervention.;Decreased level of how neck pain has affected the ability to perform activities of daily living, assessed using the Neck Related Disability Index questionnaire. This data will be collected before the intervention and at the follow-up of 1 week and 1 month.;Improved anxiety level, assessed using the Generalized Anxiety Disorder Scale (GAD-7). This data will be collected before the intervention and at the follow-up of 1 week and 1 month.;Decreased muscle activity, assessed using surface electromyography. This data will be collected before the intervention and 30 minutes later.